ANALYST RECOMMANDATIONS : AstraZeneca, BAE, Ferguson, First Bancorp, Gilead Sciences...

Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.

 

• AstraZeneca: Stifel starts tracking as Buy, targeting GBp 12,300.
• Aveva: Jefferies downgrades from hold to underperform with a target of GBp 2,000.
• BAE Systems:  Societe Generale lowers to hold from buy. PT down 11% to 667 pence.
• Dollar tree: BMO Capital Markets upgrades to outperform from market perform. PT up 21% to $170.
• Epam Systems: Piper Sandler downgrades to neutral from overweight. PT up 7.2% to $410.
• Ferguson: Jefferies downgrades from buy to hold with a GBp 12,374 target.
• First Bancorp.: Raymond James reinstated coverage with a recommendation of outperform. PT up 9.4%.
• Foot Locker: Citi cut the recommendation on Foot Locker Inc. to sell from buy.
• Gilead Sciences: BMO Capital Markets moves to market perform from outperform. PT up 6.3% to $65.
• Jack in the Box: Gordon Haskett downgrades to hold from buy. PT up 10% to $96.
• QinetiQ: J.P. Morgan upgrades from Underweight to Neutral with a target of GBp 320.
• The TJX Companies: Cowen lowers PT to $72 from $88. Maintains outperform rating.